CKD is managed on a lab cadence, but the readings that change management between visits are blood pressure and weight. Both can be captured at home without a phlebotomy appointment.
Nephrology runs on periodic labs, and nothing here replaces them. What remote monitoring adds is the interval: blood pressure and weight both move early when fluid status shifts, and both are capturable at home daily rather than quarterly.
Resistant hypertension is the most common reason a CKD patient needs more contact than the lab schedule provides, and it’s exactly what home blood pressure trending is good at surfacing, particularly when paired with objective adherence data that separates a failing regimen from an untaken one.
There is a billing decision worth getting right at enrolment. A patient with CKD plus a second qualifying condition belongs in CCM. A patient whose care burden is driven by the kidney disease alone belongs in PCM. Enrolling them in the wrong one is the single most common reason a nephrology programme’s claims come back denied.
Count the conditions before you enrol. CCM needs two or more. PCM covers the single dominant condition. A patient cannot be in both in the same calendar month, so the conflict should be flagged at enrolment rather than at billing.
Four signals that move between lab draws.
| Signal | Device | Common alert threshold | What the team does |
|---|---|---|---|
| Blood pressure | Cellular BP monitor | 7-day average above the patient’s individual goal | Titration review. Resistant hypertension is the common finding. |
| Weight | Cellular scale | Rapid gain suggesting fluid retention | Same-day review of fluid status and diuretic dosing. |
| Medication adherence | Adherence sensor | Clustered missed antihypertensive doses | Separates a regimen that is not working from one that isn’t being taken. |
| Glucose | Glucose meter | <70 or >250 mg/dL | Diabetic nephropathy is the leading cause of CKD in this panel. |
Alert thresholds are configured per patient by the ordering clinician and adjusted over time. The values above are common starting points, not clinical guidance, and nothing here establishes a standard of care. Reimbursement figures are approximate national non-facility Medicare averages and vary by locality, facility status, payer and calendar year: verify current rates at cms.gov or with your MAC before you bill.
Cellular, and shipped activated.
Three cuff sizes with irregular-heartbeat detection.
RPM 99454Step-on weights as a fluid-status proxy between visits.
RPM 99454For the diabetic nephropathy share of the panel.
RPM 99454Objective dose records for complex antihypertensive regimens.
RTM 98975CKD plus a second qualifying chronic condition.
99490 · 99439When CKD alone drives the care burden.
99424–99427BP and weight data plus monthly management time.
99453 · 99454 · 99457The 30 days after a renal admission.
99495 · 99496Renal dosing review, where errors carry real consequence.
99605–99607CKD stage, comorbidity count and transplant status determine both the monitoring design and the correct code family.
Count the conditions driving the burden. Getting this wrong at enrolment is the main source of denials.
A cuff for everyone, a scale where fluid status is being tracked.
Your team works 7-day averages and weight trends rather than isolated readings.
Time and transmission days documented against the right code family.
Patients in stages 3 to 5, patients with resistant hypertension, and post-transplant patients where adherence and blood pressure control carry outsized consequences.
The common thread is a patient whose management would change if you could see blood pressure and weight between lab draws, rather than one whose care is fully determined by the lab schedule.
Count the conditions driving the care burden. Two or more qualifying chronic conditions means CCM (99490, 99439). One dominant condition, the kidney disease alone, means PCM (99424–99427).
A patient cannot be enrolled in both during the same calendar month. This is the most frequent cause of denied claims in nephrology programmes, and it’s entirely preventable at enrolment.
No. eGFR, creatinine, potassium and the rest of the renal panel come from labs, and nothing in a home monitoring programme substitutes for them.
What home monitoring adds is the interval between draws, where blood pressure and weight can change management and where a patient would otherwise be invisible for weeks at a time.
Programme design differs substantially for patients on dialysis, since fluid status is managed through the dialysis prescription and the monitoring questions change accordingly. Pre-dialysis CKD and post-transplant patients are the more common enrolment groups.
We scope dialysis-adjacent programmes case by case rather than applying a standard template.
Bring your CKD stage distribution and comorbidity mix. We’ll map the correct code family before enrolment rather than after a denial.
Practical guidance on remote monitoring, devices and billing. Updated with every new post.
Compare RPM and CCM platforms on the five things that decide real-world performance, then implement an RPM program step by step with 2026 CPT rates.
Read articleCellular or Bluetooth for RPM blood pressure? What CPT 99445 changed in 2026, why 78% of over-65s owning a smartphone breaks the usual argument, and how to match devices per patient.
Read articleA measure-by-measure map of what RPM, CCM and APCM can actually influence, the CBP specification detail most programs miss, and why PDC targeting should start at 79%.
Read articleInterested in a demo or just general questions? Fill out the form below and a representative will respond shortly!
